MetaCap

Vericel (VCEL) News

NASDAQ: VCELHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

57.52-0.74 (-1.27%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

VCEL news summary

We found 15 recent headlines mentioning Vericel (VCEL): 4 in the past week and 13 in the past 30 days, most often from Nasdaq, GlobeNewswire, Seeking Alpha. For price context, VCEL is down 1.27% at $57.52. The most recent story, "REGN Gets FDA Nod for Livsayis in Generalized Myasthenia Gravis", was published by Nasdaq on Nov 19, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Vericel headlines

Stocks mentioned alongside VCEL

Compare VCEL